Eli Lilly’s Omvoh (mirikizumab-mrkz) has shown continued benefit after four years in a Phase III open-label extension trial ...
The CDC no longer recommends routine Covid-19 booster immunisation or the combined use of the varicella and MMR jabs.
The lifting of the FDA’s clinical hold on Neurizon’s drug will pave the way for its investigation in the HEALEY-ALS trial.
Italy-based biotech firm NanoPhoria Bioscience has announced the initial closing of its Series A funding round, raising ...
Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...
Chiesi Group and Arbor have formed an exclusive partnership and licensing deal for the latter’s investigational gene editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback